Test 5: Pharmacogenomics Flashcards
What is Pharmacogenetics?
The study of variations in human genes that are responsible for different responses to drug therapy.
-Variation of a single gene (!) or relatively few genes influencing a drug’s response
-Seeks to correlate phenotypic biomarkers with responses
What is Pharmacogenomics?
Involves identifying drug response markers at the level of disease, drug metabolism, or drug target.
-Encompasses the genome (all genes - whole genetic makeup)
-Involves DNA sequencing and gene mapping to identify genetic basis for variations in drug efficacy, metabolism, and transport
-Study of how chromosomal variations effect drug response
What is DNA?
-Main constituent of chromosomes
-Carrier of genetic information
What is an Allele?
2 or more forms of a gene that occupy a specific position on a specific chromosome
What is Allele Frequency?
The fraction or percentage of times a specific allele is observed in proportion to the total of all possible alleles that could occur at a specific location on a chromosome.
What is a Chromosome?
DNA containing structure that contains all or most of the genes of an organism
-largest is number 1
What is a Gene?
A sequence of DNA that occupies a specific position on the chromosome & determines a particular characteristic in an organism.
-Length of DNA that codes for a specific protein
What is Genotype?
-A representation of an organism’s genetic makeup or the particular set of genes that the organism possesses
-Ex: BB, Bb, or bb
What is Heterozygous?
Having two different alleles for the same trait
What is Homozygous?
Having an identical allele for a single trait
What is Phenotype?
The observable physical or biochemical characteristics of the organism’s genetic makeup
-Ex: Brown or blue eyes
What is Polymorphism?
A specific genetic alteration; occurs in more than 1% of the population.
-Any genetic variation in the DNA sequence (occur anywhere on the genome)
-Can be used interchangeably with variant
Variations in DNA sequence that occur in at least 1% of population
What is a Single Nucleotide Polymorphism (SNP)?
The most common type of genetic or allelic variation.
-Pair based substitutions that occur in the genome
-1 nucleotide is exchanged for another in a given position; occur anywhere on the genome
-A.k.a. Point Mutation
Genes specify the _____. Alleles specify ________. (Blue Box)
Genes specify the trait. Alleles specify what form the gene takes.
What does PM, IM, EM, and UM stand for?
Poor, intermediate, extensive, or ultra-rapid metabolizer phenotype
Polymorphisms are variations in the _____ sequence that occur in at least _____% of the population (Blue Box!)
Polymorphisms are variations in the DNA sequence that occur in at least 1% of the population.
What are the 3 areas of variations with Polymorphisms?
1) Drug-metabolizing enzymes
2) Enzyme receptor genes
3) Drug transporter genes
What are the allele activity scores?
-Range 0 > 3
-0 = PM
-0.5 = IM
-1.0 = normal fxn
-1.0-2.0 = EM
-> 2 = UM
What is the function of Phase 1 Drug Metabolizing Enzymes?
-CYP450 enzymes, biotransformation of over 75% of prescription drugs
-Clinical Ex: CYP2D6 – responsible for O-demethylation of Codeine to Morphine
What would the effect of PM, IM, EM, and UM due to drug-metabolizing enzymes polymorphisms?
-PM: insufficient analgesia
-IM: insufficient analgesia
-EM: desired effect
-UM: increased adverse effects
What is the recommended dosing adjustments for PM, IM, EM, and UM due to drug-metabolizing enzymes polymorphisms?
PM: alternative agent
IM: standard dose
EM: standard dose
UM: alternative agent
What is the function of Phase 2 enzymes?
-Conjugation (enhance elimination of endo/exogenous substances)
-Clinical Ex: UGT1A1 – responsible for clearance of Irinotecan
-Conjugates glucuronic acid into lipophilic molecules
-UGT1A1 *6 & *28 decreases the clearance
What are the effects of Phase 2 enzyme polymorphism?
-Can diminish drug elimination
-Can increase risk for toxicities
Individuals homozygous for UGT1A1*28 have 60-70% increased levels of circulating unconjugated bilirubin due to a 30% reduction in UGT1A1 activity
What are the effects from genetic differences in transporter genes?
-Alter drug disposition and response
-May increase risk for toxicities
-Mediate selective uptake and efflux of endogenous compounds
-Important role in determining plasma and tissue concentrations